Skip to main content

Clinical Aspects of Antiemesis: Role of the 5-HT, Antagonists

  • Chapter
  • First Online:
Serotonin

Part of the book series: Medical Science Symposia Series ((MSSS,volume 5))

  • 157 Accesses

Abstract

Development of effective antiemetics has depended upon understanding of the emetic reflex arc and identification of significant neurotransmitter receptors within that reflex arc. Appreciation of the role of histaminergic, cholinergic, and dopaminergic receptors led to development of the first generation of antiemetics. The increased efficacy of high-dose metoclopramide (an antidopaminergic agent) was later found to be due at least in part to additional blockade of serotonergic (5-HT3) neurotransmitter receptors. Pure 5-HT3antagonists now allow effective antiemesis without antidopaminergic toxicity. However recent studies concerning dose-response effects and schedule effects with 5-HT3receptor blockers suggest that additional factors must also be identified to fully understand the physiology and pharmacology of chemotherapy-induced emesis and antiemetic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Gralla, R.J., Itri, L.M., Pisko, S.E., Squillante, A.E., Kelsen, D.P., Braun, D.W., Bordin, L.A., Braun, T.J., and Young, C.W. (1981) Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting’, N. Engl. J. Med. 305, 905–909.

    Article  CAS  Google Scholar 

  2. Grunberg, S.M., Akerley, W.L., Krailo, M.D., Johnson, K.B., Baker, C.R., and Cariffe, P.A. (1986) ‘Comparison of metoclopramide and metoclopramide plus dexamethasone for complete protection from cisplatinum-induced emesis’, Cancer Invest. 4, 379–385.

    Article  CAS  Google Scholar 

  3. Grunberg, S.M., Stevenson, L.L., Russell, C.A., and McDermed, J.E. (1989) ‘Dose ranging phase I study of the serotonin antagonist GR38032F for prevention of cisplatin-induced nausea and vomiting’, J. Clin. Oncol. 7, 1137–1141.

    Article  CAS  Google Scholar 

  4. Hesketh, P.J., Twaddell, T., and Finn, A. (1990) ‘A possible role for cisplatin (DDP) in the transient hepatic enzyme elevations noted after ondansetron administration’, Proc. Am. Soc. Clin. Oncol. 9, Al250.

    Google Scholar 

  5. Lane, M., Grunberg, S.M., Lester, E.P., Sridhar, K.S., and Sanderson, P.E. (1990) ‘A double-blind comparison of three dose levels of IV ondansetron in the prevention of cisplatin-induced nausea and vomiting’, Proc. Am. Soc. Clin. Oncol. 9, Al271.

    Google Scholar 

  6. Clark, R.A., Kris, M.D., Gralla, R.J., and Tyson, L.B. (1990) ‘Serotonin antagonists demonstrate antiemetic effectiveness without extrapyramidal symptoms: analysis of studies with 3 new agents in 155 patients’, Proc. Am. Soc. Clin. Oncol. 9, Al245.

    Google Scholar 

  7. Roila, F., Tonato, M., Cognetti, F., Cortesi, E., Favalli, G., Marangolo, M., Amadori, D., Bella, M.A., Gramazio, V., Donati, D., Ballatori, E., Del Favero, A. (1991) ‘Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone’, J. Clin. Oncol. 9, 675–678.

    Article  CAS  Google Scholar 

  8. Grunberg, S.M., Groshen, S., Robinson, D.C., Stevenson, L.L., Sanderson, P. E. (1990) ‘Correlation of anti-emetic efficacy and plasma levels of ondansetron’, Eur. J. Cancer 26, 879–882.

    Article  CAS  Google Scholar 

  9. Beck, T.M., Madajewicz, S., Navari, R.M., Pendergrass, K., Lester, E.P., House, K.W., and Bryson, J.C. (1992) ‘A double-blind, stratified, randomized comparision of IV ondansetron administered as a multiple-dose regimen vs two single-dose regimens in the prevention of cisplatin-induced nausea and vomiting’, Proc. Am. Soc. Clin. Oncol. 11, A1311.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Grunberg, S.M. (1993). Clinical Aspects of Antiemesis: Role of the 5-HT, Antagonists . In: Vanhoutte, P.M., Saxena, P.R., Paoletti, R., Brunello, N., Jackson, A.S. (eds) Serotonin. Medical Science Symposia Series, vol 5. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1920-7_18

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1920-7_18

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4849-1

  • Online ISBN: 978-94-011-1920-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics